Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing
Xiaoshu Xu, Augustine Chemparathy, Leiping Zeng, et al.
Molecular Cell (2021) Vol. 81, Iss. 20, pp. 4333-4345.e4
Open Access | Times Cited: 283

Showing 1-25 of 283 citing articles:

Drug delivery systems for RNA therapeutics
Kalina Paunovska, David Loughrey, James E. Dahlman
Nature Reviews Genetics (2022) Vol. 23, Iss. 5, pp. 265-280
Open Access | Times Cited: 812
CRISPR technology: A decade of genome editing is only the beginning
Joy Y. Wang, Jennifer A. Doudna
Science (2023) Vol. 379, Iss. 6629
Closed Access | Times Cited: 601
High-content CRISPR screening
Christoph Bock, Paul Datlinger, Florence M. Chardon, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 371
The CRISPR-Cas toolbox and gene editing technologies
Guanwen Liu, Qiupeng Lin, Shuai Jin, et al.
Molecular Cell (2021) Vol. 82, Iss. 2, pp. 333-347
Open Access | Times Cited: 260
Rational combinations of targeted cancer therapies: background, advances and challenges
Haojie Jin, Liqin Wang, René Bernards
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 3, pp. 213-234
Closed Access | Times Cited: 246
High-content CRISPR screening
Christoph Bock, Paul Datlinger, Florence M. Chardon, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 204
CRISPR-based genome editing through the lens of DNA repair
Tarun S. Nambiar, Lou Baudrier, Pierre Billon, et al.
Molecular Cell (2022) Vol. 82, Iss. 2, pp. 348-388
Open Access | Times Cited: 154
Advances in CRISPR therapeutics
Michael Chavez, Xinyi Chen, Paul B. Finn, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 1, pp. 9-22
Open Access | Times Cited: 112
Adeno-Associated Virus Toolkit to Target Diverse Brain Cells
Rosemary C. Challis, Sripriya Ravindra Kumar, Xinhong Chen, et al.
Annual Review of Neuroscience (2022) Vol. 45, Iss. 1, pp. 447-469
Open Access | Times Cited: 98
Multidimensional control of therapeutic human cell function with synthetic gene circuits
Hui-Shan Li, Divya V. Israni, Keith A. Gagnon, et al.
Science (2022) Vol. 378, Iss. 6625, pp. 1227-1234
Open Access | Times Cited: 98
CRISPR/Cas-mediated plant genome editing: outstanding challenges a decade after implementation
Teodoro Cardi, Jana Murovec, Allah Bakhsh, et al.
Trends in Plant Science (2023) Vol. 28, Iss. 10, pp. 1144-1165
Open Access | Times Cited: 86
Drug delivery systems for CRISPR-based genome editors
Victoria J. Madigan, Feng Zhang, James E. Dahlman
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 11, pp. 875-894
Closed Access | Times Cited: 74
Precise cut-and-paste DNA insertion using engineered type V-K CRISPR-associated transposases
Connor J. Tou, Benno C. Orr, Benjamin P. Kleinstiver
Nature Biotechnology (2023) Vol. 41, Iss. 7, pp. 968-979
Closed Access | Times Cited: 73
Comprehensive assessment of miniature CRISPR-Cas12f nucleases for gene disruption
Changchang Xin, Jianhang Yin, Shaopeng Yuan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 70
Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing
Xiangfeng Kong, Hainan Zhang, Guoling Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 58
CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi
Louise Bendixen, Trine I. Jensen, Rasmus O. Bak
Molecular Therapy (2023) Vol. 31, Iss. 7, pp. 1920-1937
Open Access | Times Cited: 53
Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox
Eugene V. Koonin, Jonathan S. Gootenberg, Omar O. Abudayyeh
Biochemistry (2023) Vol. 62, Iss. 24, pp. 3465-3487
Open Access | Times Cited: 52
Evolutionary mining and functional characterization of TnpB nucleases identify efficient miniature genome editors
Guanghai Xiang, Yuanqing Li, Jing Sun, et al.
Nature Biotechnology (2023) Vol. 42, Iss. 5, pp. 745-757
Closed Access | Times Cited: 49
An engineered hypercompact CRISPR-Cas12f system with boosted gene-editing activity
Tong Wu, Chang Liu, Siyuan Zou, et al.
Nature Chemical Biology (2023) Vol. 19, Iss. 11, pp. 1384-1393
Open Access | Times Cited: 47
Light‐Guided Genetic Scissors Based on Phosphorene Quantum Dot
Zhi Chen, Hao Huang, Jiefeng Deng, et al.
Laser & Photonics Review (2024) Vol. 18, Iss. 11
Closed Access | Times Cited: 30
CRISPR/Cas-based nucleic acid detection strategies: Trends and challenges
Jian Zhou, Zhuo Li, Joshua Seun Olajide, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e26179-e26179
Open Access | Times Cited: 23
Rapid in silico directed evolution by a protein language model with EVOLVEpro
Kaiyi Jiang, Zhaoqing Yan, Matteo Di Bernardo, et al.
Science (2024)
Closed Access | Times Cited: 21
Epigenome editing technologies for discovery and medicine
Sean R. McCutcheon, Dahlia Rohm, Nahid Iglesias, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 8, pp. 1199-1217
Closed Access | Times Cited: 18
Robust genome editing activity and the applications of enhanced miniature CRISPR-Cas12f1
Soo-Ji Park, Sungjin Ju, Won Jun Jung, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
High-throughput continuous evolution of compact Cas9 variants targeting single-nucleotide-pyrimidine PAMs
Tony P. Huang, Zachary Heins, Shannon M. Miller, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 1, pp. 96-107
Open Access | Times Cited: 69
Page 1 - Next Page

Scroll to top